Despite the improving accuracy of BG monitoring devices [5,6] and the growing development of decision support systems [7,8], suboptimal insulin replacement remains common in T1D, leading to excess mortality and complication rates that are still significantly higher when compared to the general population [9,10]. The gene discussed is INS; the disease is type 1 diabetes mellitus.